Orally administered peptides to ameliorate atherosclerosis

Details Orally administered peptides to ameliorate atherosclerosis Orally administered peptides to ameliorate atherosclerosis

A - Human Necessities

61

K

A61K 38/10 (2006.01) A61K 38/17 (2006.01) A61P 9/10 (2006.01) C07K 7/08 (2006.01) C07K 14/775 (2006.01)

Patent

CA 2420222

This invention provides novel peptides that ameliorate one or more symptoms of atherosclerosis (see Figure 23). The peptides comprises at least one class A amphipathic helix and at least one D-amino acid. The peptides are highly stable and readily administered via an oral route.

La présente invention concerne de nouveaux peptides capables d'améliorer un ou plusieurs symptômes de l'athérosclérose. Ces peptides contiennent au moins une hélice amphipathique de classe A et au moins un acide aminé D. De plus, ces peptides sont très stables et s'administrent facilement per os.

Affiliated with

Also associated with

Rating

Orally administered peptides to ameliorate atherosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Orally administered peptides to ameliorate atherosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orally administered peptides to ameliorate atherosclerosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2037445